GALECTO BIOTECH ApS: Financial statements 2016
CVR: 34878366
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2016. In 2016, the company reported a gross profit of EUR -1,338,209 and a net result of EUR -1,842,834 compared with EUR -503,972 the year before. Equity in the 2016 report amounted to EUR -6,459,739.
- Gross Profit
- EUR -1,338,209
- Profit/Loss
- EUR -1,842,834
- Equity
- EUR -6,459,739
- Total Assets
- EUR 1,992,218
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -1.3 mio. EUR | -1.8 mio. EUR | -6.5 mio. EUR | - |
| 2015 | - | 865 t. EUR | -504 t. EUR | -4.6 mio. EUR | - |
| 2014 | - | -15 mio. | -12 mio. | -30.6 mio. | - |
| 2013 | - | -15 mio. | -17.1 mio. | -18.6 mio. | - |
Find more companies like GALECTO BIOTECH ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
GALECTO BIOTECH ApS has published its annual report for 2015. Gross profit came to DKK 864,833, and the net result was DKK -503,972.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.